atrial fibrillation

Latest Headlines

Latest Headlines

Boehringer taps WellPoint's outcomes data to develop new a-fib drugs

Boehringer Ingelheim is working with managed care giant WellPoint in an effort to use real-world data to inform the development of new treatments of atrial fibrillation, keeping up with a sweeping trend in cardiovascular R&D.

AliveCor heart monitor, app added to GreatCall's health-focused smartphone

GreatCall, maker of mobile health and safety apps, is adding the AliveCor Heart Monitor for detecting atrial fibrillation to its offerings. Alivecor's electrocardiogram can now be mounted to back of the GreatCall3 smartphone and used with the AliveECG app.

Swedes, Harvard and more find success with DNA test for Afib risks

Researchers in Sweden and colleagues in Europe and the U.S. say they've found success with a blood test that screens for 12 biomarkers pointing to an increased likelihood of atrial fibrillation, an abnormal heart rhythm that can cause all kinds of cardiac health risks.

Researchers diagnose atrial fibrillation via webcam

Atrial fibrillation causes uneven blood flow, which results in subtle changes in facial skin color. Researchers were able to use that to diagnose AF patients in a small pilot study by using video of a person's face in conjunction with a software analysis of skin color.

St. Jude flexible cardiac catheter approved in EU, aims for FDA

St. Jude Medical is hoping to strengthen its franchise in ablation catheters--thin, flexible wires inserted non-surgically into the heart to treat cardiac arrhythmia. Its FlexAbility irrigated ablation catheter has garnered a CE Mark in Europe, where it has marketed the TactiCath contact-force sensing irrigated ablation catheter since 2012. The company hopes to get FDA approval by year end for both FlexAbility and TactiCath.

Advanced Cardiac Therapeutics raises $7M-plus for ablation catheter technology

Advanced Cardiac Therapeutics closed a new round of equity financing to support development of its innovative ablation catheter for atrial fibrillation.

Medtronic gives it another go with atrial fibrillation device

Medtronic is looking make its device the first to be FDA-approved for long-running atrial fibrillation, shaking off a 2011 setback and kicking-starting enrollment in a new pivotal trial.

Topera snags FDA OK for latest heart-mapping tech

Topera Medical picked up FDA clearance for the latest generation of its 3-D Mapping System, a device designed to help diagnose cardiac arrhythmias without invasive surgery.

AtriCure grabs ablation device maker Estech for $34M

AtriCure is set to acquire California-based surgical ablation device maker Estech in a deal worth at least $34 million and almost double that amount down the line.

Daiichi's a-fib drug aces PhIII, faces crowded market

Daiichi Sankyo's atrial fibrillation-treating edoxaban posted promising results in Phase III, matching the stroke-prevention prowess of warfarin with a better safety profile, but the drug may struggle to carve out market share in a cluttered space.